Mini review · 15 Dec 2025
Conference abstractPublished 30 Nov 2020
Diclofenac: Exploring the microbial degradation pathway
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A wide range of unique chemicals of emerging concern (CECs), including pharmaceuticals, are continuously introduced into natural environment including water and soil matrices, mainly from hospital and municipal wastewater or manufactures. Currently, diclofenac (DCF; [2-(2,6-dichloroanilino)phenyl] acetic acid), classified as nonsteroidal anti-inflammatory drug (NSAID) constitutes one of the most serious problem worldwide. Due to its frequent occurrence in wastewaters and natural waters diclofenac is even proposed as a suitable marker for anthropogenic pollution, which confirmed the great importance of NSAIDs environmental pollution. Moreover, as a consequence of its environmental significance, diclofenac is currently classified in the watch list, which contains the most important candidates for a supplemented list of priority substances for the WFD (European Water Framework Directive). Up to now, only a few bacterial strains able to DCF decomposition have been described. Moreover, so far only a few of the initial metabolites of the microbial degradation of diclofenac (including hydroxylated and lactam derivatives) have been identified. Structural and metabolic changes occurring in the bacterial cells under the influence of this drug also remain poorly characterized. The main aim of this research was to describe the microbial degradation pathway of DCF in Pseudomonas strains. The analysis include high performance liquid chromatography, gas chromatography coupled with mass spectrometry, measurement of specific enzymes activity presumably involved in diclofenac degradation e.g. hydroquinone 1,2-dioxygenase, hydroxyquinol 1,2-dioxygenase, catechol 1,2-dioxygenase, catechol 2,3-dioxygenase, protocatechuate 3,4-dioxygenase and protocatechuate 4,5-dioxygenase. The influence of diclofenac on bacteria was determined by analysis of the composition and content of fatty acids (FAME, fatty acid methyl esters), which build the bacterial membrane. Toxicity of DCF was evaluated by calculation of EC50 value.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Research and Pharmacy.
Opinion · 15 Dec 2025
Amr: Global threat, unified one health strategy
Perspective · 15 Dec 2025
Targeted therapies transform cancer & support
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research and Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joanna zur”
- BylineArticles whose byline prints “Agnieszka Nowak”
- BylineArticles whose byline prints “Justyna Michalska”
- BylineArticles whose byline prints “Danuta Wojcieszynska”
- BylineArticles whose byline prints “Urszula Guzik”
